相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mycobacterium tuberculosis and SARS-CoV-2 Coinfections: A Review
Narjess Bostanghadiri et al.
FRONTIERS IN MICROBIOLOGY (2022)
Mycobacterium tuberculosis and Pulmonary Rehabilitation: From Novel Pharmacotherapeutic Approaches to Management of Post-Tuberculosis Sequelae
Andreea-Daniela Meca et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
Clinical features and outcomes of COVID-19 admissions in a population with a high prevalence of HIV and tuberculosis: a multicentre cohort study
Arifa Parker et al.
BMC INFECTIOUS DISEASES (2022)
High-sensitivity C-reactive protein in HIV care: Tuberculosis diagnosis and short-term mortality in a cohort of Kenyan HIV patients in the DREAM programme
Fausto Ciccacci et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Pulmonary tuberculosis screening in anti-retroviral treated adults living with HIV in Kenya
Jill K. Gersh et al.
BMC INFECTIOUS DISEASES (2021)
Impact of hematocrit on point-of-care C-reactive protein-based tuberculosis screening among people living with HIV initiating antiretroviral therapy in Uganda
Sandra Z. Mwebe et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2021)
Evaluation of Host Serum Protein Biomarkers of Tuberculosis in sub-Saharan Africa
Thomas C. Morris et al.
FRONTIERS IN IMMUNOLOGY (2021)
Variations of Serum Oxidative Stress Biomarkers under First-Line Antituberculosis Treatment: A Pilot Study
Andreea-Daniela Meca et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Old biomarkers in tuberculosis management: are they still useful? a systematic review
Lara Fusani et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2021)
Evaluation of prognostic significance of hematological profiles after the intensive phase treatment in pulmonary tuberculosis patients from Romania
Simona Stefanescu et al.
PLOS ONE (2021)
Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients
Ibrahim Halil Ozdemir et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2021)
Evaluation of the diagnostic performance of laboratory-based c-reactive protein as a triage test for active pulmonary tuberculosis
Thomas H. A. Samuels et al.
PLOS ONE (2021)
Prediction of Treatment Outcome with Inflammatory Biomarkers after 2 Months of Therapy in Pulmonary Tuberculosis Patients: Preliminary Results
Simona Stefanescu et al.
PATHOGENS (2021)
Clinical Characteristics and the Long-Term Post-recovery Manifestations of the COVID-19 Patients-A Prospective Multicenter Cross-Sectional Study
Abu Taiub Mohammed Mohiuddin Chowdhury et al.
FRONTIERS IN MEDICINE (2021)
A Clinical Prediction Score Including Trial of Antibiotics and C-Reactive Protein to Improve the Diagnosis of Tuberculosis in Ambulatory People With HIV
Tom H. Boyles et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Clinical profiles of subclinical disease among pulmonary tuberculosis patients: a prospective cohort study in South Korea
Jinsoo Min et al.
BMC PULMONARY MEDICINE (2020)
C-Reactive Protein and Cancer-Diagnostic and Therapeutic Insights
Peter C. Hart et al.
FRONTIERS IN IMMUNOLOGY (2020)
Difficulties with the implemented xpert MTB/RIF for determining diagnosis of pulmonary and extrapulmonary tuberculosis in adults and children
Ni Made Mertaniasih et al.
JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES (2020)
Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation
Sultan Ahmed et al.
ANTIBIOTICS-BASEL (2020)
A lung image reconstruction from computed radiography images as a tool to tuberculosis treatment control
Marcela de Oliveira et al.
JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES (2019)
Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study
Kathrin Zurcher et al.
LANCET INFECTIOUS DISEASES (2019)
Plasma Profiles of Inflammatory Markers Associated With Active Tuberculosis in Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Positive Individuals
Oskar Olsson et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
A multicenter evaluation of a point of care CRP Test
Volkher Scharnhorst et al.
CLINICAL BIOCHEMISTRY (2019)
Opportunities for Overcoming Mycobacterium tuberculosis Drug Resistance: Emerging Mycobacterial Targets and Host-Directed Therapy
Eveline Torfs et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Designing noninferiority tuberculosis treatment trials: Identifying practical advantages for drug regimens with acceptable effectiveness
Piero L. Olliaro et al.
PLOS MEDICINE (2019)
Treatment of Drug - Susceptible Tuberculosis
Beth Shoshana Zha et al.
CLINICS IN CHEST MEDICINE (2019)
The Immune Escape Mechanisms of Mycobacterium Tuberculosis
Weijie Zhai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Yield and Efficiency of Intensified Tuberculosis Case-Finding Algorithms in 2 High-Risk HIV Subgroups in Uganda
Fred C. Semitala et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2019)
Detection of Mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and GeneXpert® MTB/RIF assay
Ghulam Rasool et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2019)
An Observational Case-Control Study to Determine Human Immunodeficiency Virus and Host Factor Influence on Biomarker Distribution and Serodiagnostic Potential in Adult Pulmonary Tuberculosis
Khayriyyah Mohd Hanafiah et al.
TROPICAL MEDICINE AND INFECTIOUS DISEASE (2019)
Diagnosing pulmonary tuberculosis by pooling induced sputum
Mei Ying Chew et al.
JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES (2019)
Plasma levels of CRP, neopterin and IP-10 in HIV-infected individuals with and without pulmonary tuberculosis
Fausto Ciccacci et al.
JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES (2019)
C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa
Adrienne E. Shapiro et al.
AIDS (2018)
Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management
Emanuele Pontali et al.
CURRENT OPINION IN PULMONARY MEDICINE (2018)
Rapid molecular diagnostics for multi-drug resistant tuberculosis in India
Rajeswari Ramachandran et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2018)
Regulation of Three Virulence Strategies of Mycobacterium tuberculosis: A Success Story
Niels A. Zondervan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Trends in C-Reactive Protein, D-Dimer, and Fibrinogen during Therapy for HIV-Associated Multidrug-Resistant Tuberculosis
Patrick G. T. Cudahy et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study
Fiona Mendelson et al.
BMC INFECTIOUS DISEASES (2018)
Evaluation of Tuberculosis Treatment Response With Serial C-Reactive Protein Measurements
Douglas Wilson et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis
C. Yoon et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2017)
Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study
Christina Yoon et al.
LANCET INFECTIOUS DISEASES (2017)
Routinely detected indicators in plasma have a predictive effect on the identification of HIV-infected patients with non-tuberculous mycobacterial and tuberculous infections
Ren-tian Cai et al.
INFECTIOUS DISEASES OF POVERTY (2017)
Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique
Marco Floridia et al.
CLINICAL INFECTIOUS DISEASES (2017)
Screening and treatment of latent tuberculosis infection among HIV-infected patients in resource-rich settings
Ada W. C. Lin et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2016)
Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults
Maunank Shah et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Validation and evaluation of eight commercially available point of care CRP methods
Nannette Brouwer et al.
CLINICA CHIMICA ACTA (2015)
Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis
A. Jayakumar et al.
TUBERCULOSIS (2015)
Tuberculosis and HIV Coinfection
Judith Bruchfeld et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Inflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems
Daniel Fuster et al.
AIDS (2014)
Diagnostic accuracy and clinical role of rapid C-reactive protein testing in HIV-infected individuals with presumed tuberculosis in South Africa
P. K. Drain et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Point-of-Care C-Reactive Protein Testing to Facilitate Implementation of Isoniazid Preventive Therapy for People Living With HIV
Christina Yoon et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis
S. D. Lawn et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Diagnostic Value of Dynamics Serum sCD163, sTREM-1, PCT, and CRP in Differentiating Sepsis, Severity Assessment, and Prognostic Prediction
Longxiang Su et al.
MEDIATORS OF INFLAMMATION (2013)
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis
W-J. Su et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Performance of Serum C-Reactive Protein as a Screening Test for Smear-Negative Tuberculosis in an Ambulatory High HIV Prevalence Population
Douglas Wilson et al.
PLOS ONE (2011)
A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing
Jeffrey D McBride et al.
JOURNAL OF NANOBIOTECHNOLOGY (2008)
分享论文
